These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 9310289

  • 1. Activation of the HIV type 1 long terminal repeat and viral replication by dimethylsulfoxide and related solvents.
    Klebanoff SJ, Mehlin C, Headley CM.
    AIDS Res Hum Retroviruses; 1997 Sep 20; 13(14):1221-7. PubMed ID: 9310289
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Poly (ADP-ribose) polymerase is involved in PMA-induced activation of HIV-1 in U1 cells by modulating the LTR function.
    Kameoka M, Tanaka Y, Ota K, Itaya A, Yoshihara K.
    Biochem Biophys Res Commun; 1999 Aug 19; 262(1):285-9. PubMed ID: 10448106
    [Abstract] [Full Text] [Related]

  • 4. RAW264 macrophages stably transfected with an HIV-1 LTR reporter gene provide a sensitive bioassay for analysis of signalling pathways in macrophages stimulated with lipopolysaccharide, TNF-alpha or taxol.
    Sweet MJ, Hume DA.
    J Inflamm; 1995 Aug 19; 45(2):126-35. PubMed ID: 7583358
    [Abstract] [Full Text] [Related]

  • 5. Potent inhibition of HIV type 1 replication by an antiinflammatory alkaloid, cepharanthine, in chronically infected monocytic cells.
    Okamoto M, Ono M, Baba M.
    AIDS Res Hum Retroviruses; 1998 Sep 20; 14(14):1239-45. PubMed ID: 9764907
    [Abstract] [Full Text] [Related]

  • 6. Activation of the human immunodeficiency virus long terminal repeat in THP-1 cells by a staphylococcal extracellular product.
    Klebanoff SJ, Kazazi F, Van Voorhis WC, Schlechte KG.
    Proc Natl Acad Sci U S A; 1994 Oct 25; 91(22):10615-9. PubMed ID: 7938001
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Interleukin-10 enhances tumor necrosis factor-alpha activation of HIV-1 transcription in latently infected T cells.
    Rabbi MF, Finnegan A, Al-Harthi L, Song S, Roebuck KA.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec 01; 19(4):321-31. PubMed ID: 9833740
    [Abstract] [Full Text] [Related]

  • 9. Activation of the human immunodeficiency virus-1 long terminal repeat by respiratory burst oxidants of neutrophils.
    Klebanoff SJ, Headley CM.
    Blood; 1999 Jan 01; 93(1):350-6. PubMed ID: 9864180
    [Abstract] [Full Text] [Related]

  • 10. CD8+ T cell supernatants of HIV type 1-infected individuals have opposite effects on long terminal repeat-mediated transcription in T cells and monocytes.
    Copeland KF, Leith JG, McKay PJ, Rosenthal KL.
    AIDS Res Hum Retroviruses; 1997 Jan 01; 13(1):71-7. PubMed ID: 8989429
    [Abstract] [Full Text] [Related]

  • 11. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
    McAllister JJ, Phillips D, Millhouse S, Conner J, Hogan T, Ross HL, Wigdahl B.
    Virology; 2000 Sep 01; 274(2):262-77. PubMed ID: 10964770
    [Abstract] [Full Text] [Related]

  • 12. Valproic acid reduces the intracellular level of glutathione and stimulates human immunodeficiency virus.
    Simon G, Moog C, Obert G.
    Chem Biol Interact; 1994 Jun 01; 91(2-3):111-21. PubMed ID: 7514959
    [Abstract] [Full Text] [Related]

  • 13. Substance P enhances HIV-1 replication in latently infected human immune cells.
    Li Y, Douglas SD, Song L, Sun S, Ho WZ.
    J Neuroimmunol; 2001 Dec 03; 121(1-2):67-75. PubMed ID: 11730941
    [Abstract] [Full Text] [Related]

  • 14. Sodium butyrate treatment of cells latently infected with HIV-1 results in the expression of unspliced viral RNA.
    Laughlin MA, Zeichner S, Kolson D, Alwine JC, Seshamma T, Pomerantz RJ, Gonzalez-Scarano F.
    Virology; 1993 Oct 03; 196(2):496-505. PubMed ID: 8372431
    [Abstract] [Full Text] [Related]

  • 15. Effects of glutathione precursors on human immunodeficiency virus replication.
    Simon G, Moog C, Obert G.
    Chem Biol Interact; 1994 Jun 03; 91(2-3):217-24. PubMed ID: 8194136
    [Abstract] [Full Text] [Related]

  • 16. NF-kappa B-dependent and -independent pathways of HIV activation in a chronically infected T cell line.
    Antoni BA, Rabson AB, Kinter A, Bodkin M, Poli G.
    Virology; 1994 Aug 01; 202(2):684-94. PubMed ID: 7913275
    [Abstract] [Full Text] [Related]

  • 17. Activation of the human immunodeficiency virus type 1 long terminal repeat by BTEB, a GC box-binding transcription factor.
    Imataka H, Mizuno A, Fujii-Kuriyama Y, Hayami M.
    AIDS Res Hum Retroviruses; 1993 Sep 01; 9(9):825-31. PubMed ID: 8257632
    [Abstract] [Full Text] [Related]

  • 18. Dimethyl sulfoxide and related polar compounds enhance infection of human T cells with HIV-1 in vitro.
    Seki J, Ikeda R, Hoshino H.
    Biochem Biophys Res Commun; 1996 Oct 23; 227(3):724-9. PubMed ID: 8886001
    [Abstract] [Full Text] [Related]

  • 19. Lactobacilli and vaginal host defense: activation of the human immunodeficiency virus type 1 long terminal repeat, cytokine production, and NF-kappaB.
    Klebanoff SJ, Watts DH, Mehlin C, Headley CM.
    J Infect Dis; 1999 Mar 23; 179(3):653-60. PubMed ID: 9952372
    [Abstract] [Full Text] [Related]

  • 20. IL-10 cooperates with TNF-alpha to activate HIV-1 from latently and acutely infected cells of monocyte/macrophage lineage.
    Finnegan A, Roebuck KA, Nakai BE, Gu DS, Rabbi MF, Song S, Landay AL.
    J Immunol; 1996 Jan 15; 156(2):841-51. PubMed ID: 8543841
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.